Innocoll initiates dosing in U.S. phase II clinical trial of CollaRx bupivacaine surgical implant Jan. 8, 2008
Promising results with antisense oligonucleotide PRO-051 in Duchenne's muscular dystrophy Jan. 7, 2008
RSS